Alliance for Pharmacy Compounding

10/23/2026

One pharmacy found $160,000 in annual savings on credit card processing. Your numbers will be your own, but they’re worth checking.

APC PFM members get exclusive rates through APC Payments. Run a free 60-second audit at https://hubs.ly/Q04BTZDF0 and see what you could save.

10/22/2026

New analysis finds pharma-funded ties among FDA advisory committee patient and consumer reps. Roughly four in 10 meetings across two decades featured a patient or consumer representative whose affiliated advocacy group takes drug company funding, according to a new Health Affairs Scholar study. Read more at https://hubs.la/Q04BTYpb0

10/22/2026

Built specifically for pharmacies, APC’s new online payment certification program is faster and less expensive than most alternatives.

ScriptSafe uses the licenses you already hold, targets a decision in 7 to 10 business days, and includes ongoing monitoring so you can accept payments online with confidence. Learn more at https://hubs.la/Q04BTVHn0.

10/21/2026

Are pharmacies being pressured to avoid a hearing? In a LinkedIn post last week, APC CEO, Scott Brunner raised concerns about reports that pharmacies are being pressured to accept board penalties rather than contest them, undermining the fair process licensees are owed. Read what Scott has to say at https://hubs.la/Q04BC0Fh0 and subscribe to his weekly newsletter, Compounding Interests, while you're there.

10/20/2026

Hype is easy to find. Evidence takes work.

Your patients are already hearing about BPC-157, TB-500, and the rest. In “Peptides at the 503A Crossroads,” Jim LaValle, RPh, CCN, chair of the International Peptide Society, shows you how to evaluate the research, spot safety concerns, and understand what to expect at the February 2027 PCAC meeting.

October 29 at 2pm ET. One hour, live or on demand, with CE credit available. Register at https://hubs.la/Q04BB-dT0

10/19/2026

Something is stirring on the peptide front.

FDA has sent an action titled “Interim Access Policy for Compounding Using Certain Peptides” to the White House Office of Management and Budget for review. OMB logged it October 14, according to https://hubs.la/Q04BBYpc0.

The text hasn’t been made public. We don’t yet know which peptides it covers, what conditions FDA may attach, or when it could be released.

We’ll share more as soon as we know more.

10/19/2026

State tax rules for compounding pharmacies are complicated in ways most businesses never have to think about, and not knowing them can cost you.

Scotty Sykes joined the APC’s Essential podcast to walk compounding pharmacy owners through what they need to know. Plus, peptide news, an update on animal-derived thyroid, and a documentation mistake you really don’t want to make.

Listen at https://hubs.la/Q04BxYrx0.

10/16/2026

https://www.linkedin.com/posts/rscottbrunner_heres-an-opportunity-to-share-what-you-know-ugcPost-7516937235028410368-wdzS/?highlightedUpdateUrn=urn%3Ali%3Aactivity%3A7516937235464818689&highlightedUpdateType=SOCIAL_SHARE&origin=SOCIAL_SHARE&utm_source=share&utm_medium=member_ios&rcm=ACoAACvFzjQB7uM5IETVRSxxROqIyYmxtaOEH4Y

Here's an opportunity to share what you know. Apply within.

10/16/2026

PCAC has recommended six peptides, and your patients are already asking about them.

Join Jim LaValle, RPh, CCN, chair of the International Peptide Society, for APC's live webinar, Peptides at the 503A Crossroads, on October. 29. He'll walk through proposed uses, dosing, adverse effects, and where each one stands with regulators.

Register today at: https://hubs.la/Q04B2Dgq0

10/16/2026

The PCCA International Summit is underway this week, and Jen and Jason from APC are on the floor at booth 900 — stop by to connect, talk membership and advocacy, and catch up on everything shaping the profession right now.